[Management of hemolytic disease of newborn].
D000028:Abortion, Induced; D000649:Amniocentesis; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001805:Blood Transfusion, Intrauterine; D002585:Cesarean Section; D004899:Erythroblastosis, Fetal / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D005319:Fetal Hemoglobin / Q000032:analysis; D005333:Fetus / Q000528:radiation effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D007751:Labor, Induced; D008722:Methods; D007744:Obstetric Labor Complications / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D011379:Prognosis; D011677:Punctures / Q000009:adverse effects; D011832:Radiation Injuries / Q000517:prevention & control; D011859:Radiography
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D005319:Fetal Hemoglobin
Tratamiento de la enfermedad hemolítica neonatal.